Molbio Diagnostics has signed a Memorandum of Understanding (MoU) for strategic collaboration with CrisprBits, a biotech start-up specializing in CRISPR gene-editing technology. The intent of this collaboration is to revolutionize point of care diagnostics by the introduction of CRISPR in Point-of-Care (POC) tests.